Mother Suffering with NCPH and Hypersplenism Successfully Delivers Baby At BirthRight by Rainbow Hospitals Hyderabad 3rd May 2024: BirthRight by Rainbow Hospitals Financial District and Star Hospitals in a collaborative effort have showcased ...
KYOTO, Japan , April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture , Japan , announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood ...
World pulmonary hypertension community to unite on May 5 to raise awareness, offer support and advocate for PH. WASHINGTON , April 24, 2024 /PRNewswire-PRWeb/ --Â The Pulmonary Hypertension Association will unite with over 80 ...
Team PHenomenal Hope (Team PH) seeks submissions for its PHenomenal Impact Fund for Global PH Research, marking the sixth consecutive year of funding innovative studies in pulmonary hypertension (PH) WHEATON, IL , Feb. 15, 2024 ...
INCHEON, South Korea , Feb. 7, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been ...
SoniVie announces enrollment completion in the REDUCED-1 pilot study TEL AVIV, Israel , Jan. 31, 2024 /PRNewswire/ -- SoniVie , an Israeli company developing a novel, proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS TM ) System ...
Team PHenomenal Hope, a nonprofit advocacy organization, has published a research paper in Pulmonary Circulation titled "Patient perspectives on pulmonary hypertension in the United States : Burdens, expectations, and goals." The study ...
TAIPEI , Oct. 30, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company will be presenting at the American Heart Association (AHA) 2023 Annual Meeting taking place in Philadelphia, PA , ...
SEOUL, South Korea , July 2, 2023 /PRNewswire/ --Â Today Zymedi, a Korean biotech venture-backed company, announced the signing of a clinical Cooperative Research and Development Agreement (CRADA) with the National Heart, Lung, and Blood ...
This is the first and only single tablet combination therapy application to be submitted for review in the U.S. for this rare, progressive disease  If approved, Janssen's comprehensive PAH portfolio has the potential to cover all ...
Health experts emphasized that seasonal variations, such as hot, humid weather or cold winters, can significantly raise or lower blood pressure ( ), highlighting the importance of regular monitoring. The blood pressure tends to vary as the ...
Metabolic risk factors like high blood pressure, elevated blood sugar, and high body mass index (BMI) are contributing to poor health and premature death globally. The latest findings from the Global Burden of Diseases, Injuries, and Risk ...
Prompt identification of stroke type may hold the key to maximizing the advantages of promptly administering blood pressure -lowering treatment during ambulance transport for patients with suspected acute stroke ( ). The findings were presented ...
Roughly 50% of those diagnosed with high blood pressure (BP), or hypertension, face the risk of long-term kidney damage, potentially leading to the need for dialysis or transplantation. ...
More than 30% of adults globally suffer from hypertension, a major controllable risk factor for cardiovascular disease and mortality. Hypertension is characterized by either high systolic blood pressure (SBP) and, or high diastolic blood pressure ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers